Literature DB >> 6742124

Positional requirements for anionic charge for ileal absorption of bile salt analogues.

L Lack, A Tantawi, C Halevy, D Rockett.   

Abstract

Previous structure-activity studies of the ileal bile salt cotransport system have suggested the idea that a coulombic interaction occurs between the negative charge of the bile salt and a cationic site on the carrier. Evidence included observations that modified bile salts with uncharged, cationic, or zwitterionic side chains were poorly transported. They did interact with this system as evidenced by their abilities to inhibit transport. Another prerequisite for coulombic interaction is positional (side-chain) specificity for the anionic grouping. [14C]chenodeoxycholyl-N-ethanolamide-O-sulfate and the 3 alpha-sulfate ester of chenodeoxycholyl-N-ethanolamide were tested for their in vivo absorption from the jejunums and ileums of anesthetized guinea pigs. Active ileal transport was estimated by subtracting jejunal absorption (passive) from ileal absorption (active and passive). Translocation of the anionic SO4(-) radical from the side chain to the 3 alpha position of the steroid decreased active ileal absorption by 95%, demonstrating a positional requirement for the anionic group for optimal transport.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6742124     DOI: 10.1152/ajpgi.1984.246.6.G745

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  2 in total

1.  Use of the intestinal bile acid transporter for the uptake of cholic acid conjugates with HIV-1 protease inhibitory activity.

Authors:  M Kågedahl; P W Swaan; C T Redemann; M Tang; C S Craik; F C Szoka; S Oie
Journal:  Pharm Res       Date:  1997-02       Impact factor: 4.200

2.  Functional expression cloning and characterization of the hepatocyte Na+/bile acid cotransport system.

Authors:  B Hagenbuch; B Stieger; M Foguet; H Lübbert; P J Meier
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.